A randomized controlled trial of pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in end-stage renal disease patients on hemodialysis

Thumbnail Image

Files

A randomized controlled trial of pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in end-stage renal disease patients on hemodialysis.pdf (73.55 KB)

Date

2017-05-09

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

https://hdl.handle.net/20.500.11888/16191

Collections

Doctor of Medicine

Endorsement

Review

Supplemented By

Referenced By